Gilead Sciences

Yahoo Finance • yesterday

Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.79

The board of Gilead Sciences, Inc. (NASDAQ:GILD) has announced that the dividend on 28th of March will be increased to $0.79, which will be 2.6% higher than last year's payment of $0.77 which covered the same period. The payment will take... Full story

Yahoo Finance • 4 days ago

Trending tickers: Intel, Alibaba, Super Micro, Lyft and Barratt Redrow

Intel (INTC) Shares in Intel (INTC) surged 6% in Tuesday's session after US vice president JD Vance advocated for using US-manufactured chips in domestic artificial intelligence (AI) systems. Fellow semiconductor manufacturer GlobalFound... Full story

Yahoo Finance • 7 days ago

3 Fabulous Dividend Stocks to Buy in February

February is the shortest month, but that doesn't mean income investors don't have much time to find great stocks. Three Motley Fool contributors believe they have identified fabulous dividend stocks to buy this month. Here's why they like... Full story

Yahoo Finance • 25 days ago

Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus

PALM BEACH, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The demand for effective pancreatic cancer treatments is and has been undeniably high. The growing number of diagnoses, with the aggressive nature of th... Full story

Yahoo Finance • 4 months ago

Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48

– Novel Investigational Combination Regimen is Advancing to Phase 3 andhas the Potential to Become the First Weekly Oral HIV Treatment – FOSTER CITY, Calif., & RAHWAY, N.J., October 19, 2024--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq... Full story

Yahoo Finance • 4 months ago

High Growth Tech Stocks to Watch in October 2024

The United States market has shown robust performance, climbing 1.1% in the last 7 days and rising 36% over the past year, with earnings anticipated to grow by 15% annually. In this promising environment, identifying high growth tech stock... Full story

Yahoo Finance • 4 months ago

How Brookfield Infrastructure, Invitation Homes And Gilead Sciences Can Put Cash In Your Pocket

How Brookfield Infrastructure, Invitation Homes And Gilead Sciences Can Put Cash In Your Pocket Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Companies with a long history of paying... Full story

Yahoo Finance • 5 months ago

Gilead Sciences, Verizon Communications And ManpowerGroup Are Winners For Passive Income

Gilead Sciences, Verizon Communications And ManpowerGroup Are Winners For Passive Income Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Companies with a long history of paying dividen... Full story

Yahoo Finance • 5 months ago

3 Dirt Cheap Stocks to Buy Right Now

By most metrics, the stock market is priced at a premium these days. But that doesn't mean bargains can't still be found. Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why th... Full story

Yahoo Finance • 5 months ago

Should You Be Worried About Gilead Sciences, Inc.'s (NASDAQ:GILD) 5.7% Return On Equity?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. We'll use ROE to examine Gilead Sciences, Inc. (NASDAQ:GIL... Full story

Yahoo Finance • 5 months ago

Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel Therapies

-- Gilead and Genesis Will Leverage the GEMS AI Platform to Generate and Jointly Optimize Molecules Against Selected Targets -- -- Gilead Receives Exclusive Rights to Develop and Commercialize Products from the Collaboration -- FOSTER CI... Full story

Yahoo Finance • 5 months ago

Gilead Sciences, Inc. (GILD): Are Hedge Funds Bullish On This Biotech Stock?

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds.In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other biotech stocks. As we have... Full story

Yahoo Finance • 6 months ago

Weekly market recap: Here's how S&P 500 sectors performed last week

US stocks concluded the week with a modest rebound, with the S&P 500 index rising by 0.5%, therefore marking the strongest consecutive daily gains of the year. The rebound in stocks helped to offset much of the losses from earlier in the... Full story

Yahoo Finance • 6 months ago

2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off

There are plenty of excellent reasons to invest in dividend stocks, including the fact that only rock-solid companies can afford to sustain payout increases for a long time. When you put your money into corporations that have been paying d... Full story

Yahoo Finance • 7 months ago

Chief Medical Officer Merdad Parsey to Leave Gilead Early 2025

FOSTER CITY, Calif., July 17, 2024--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Chief Medical Officer Merdad Parsey, MD, PhD, will leave the company early next year. While the company works to identify a succ... Full story

Yahoo Finance • 8 months ago

S&P 500, Nasdaq 100 Dip From Record Highs As Investors Take Chipmaker Profits; Energy Sector Rebounds, Yields Rise: What's Driving Markets Thursday?

S&P 500, Nasdaq 100 Dip From Record Highs As Investors Take Chipmaker Profits; Energy Sector Rebounds, Yields Rise: What's Driving Markets Thursday? After the Juneteenth holiday break, Wall Street reopened with a cautious tone, as the S&P... Full story

Yahoo Finance • 8 months ago

Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention

– First Phase 3 HIV Prevention Trial Ever to Show Zero Infections – – Independent Data Monitoring Committee Recommended That Gilead Stop the Blinded Phase of the PURPOSE 1 Trial at Interim Analysis and Offer Open-Label Lenacapavir to All... Full story

Yahoo Finance • 8 months ago

Gilead and Kite Pharma Celebrates Pride Month

NORTHAMPTON, MA / ACCESSWIRE / June 19, 2024 / Gilead Sciences Gilead and Kite Pharma teams raised Pride Month flags at our campuses last week symbolizing our united support for LGBTQ+ communities globally. Our commitment to inclusion and... Full story

Yahoo Finance • 9 months ago

Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight

Comprehensive SWOT analysis highlighting Gilead Sciences Inc's strategic positioning in the biopharmaceutical industry. Insightful examination of Gilead Sciences Inc's financial performance, including revenue growth and R&D investments. Fo... Full story

Yahoo Finance • 9 months ago

23 Most Profitable Stocks of the Last 12 Months

In this article, we discuss the 23 most profitable stocks of the last 12 months. If you want to skip our detailed analysis of these stocks, go directly to 5 Most Profitable Stocks of the Last 12 Months. The United States stock market has... Full story